Bicocca Open Archive

Logo unimib boa
PESCI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.711
EU - Europa 4.757
AS - Asia 2.200
SA - Sud America 118
AF - Africa 23
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.822
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.565
IT - Italia 952
DE - Germania 863
CN - Cina 768
SE - Svezia 736
SG - Singapore 734
IE - Irlanda 611
RU - Federazione Russa 409
UA - Ucraina 320
HK - Hong Kong 262
GB - Regno Unito 232
ID - Indonesia 149
FR - Francia 147
AT - Austria 145
CA - Canada 141
FI - Finlandia 127
BR - Brasile 103
VN - Vietnam 93
IN - India 77
DK - Danimarca 62
TR - Turchia 42
NL - Olanda 37
BE - Belgio 34
CZ - Repubblica Ceca 26
JP - Giappone 14
ES - Italia 13
IR - Iran 9
PK - Pakistan 9
RO - Romania 9
CH - Svizzera 8
KR - Corea 8
CL - Cile 7
AU - Australia 6
PT - Portogallo 5
TH - Thailandia 5
BD - Bangladesh 4
GR - Grecia 4
NZ - Nuova Zelanda 4
SC - Seychelles 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
EG - Egitto 3
IL - Israele 3
LB - Libano 3
MA - Marocco 3
NG - Nigeria 3
PL - Polonia 3
AL - Albania 2
AR - Argentina 2
DZ - Algeria 2
EC - Ecuador 2
EU - Europa 2
IQ - Iraq 2
KZ - Kazakistan 2
MD - Moldavia 2
MM - Myanmar 2
MU - Mauritius 2
MX - Messico 2
PH - Filippine 2
RS - Serbia 2
TN - Tunisia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
A1 - Anonimo 1
BH - Bahrain 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
TG - Togo 1
VE - Venezuela 1
Totale 17.822
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.538
Fairfield 907
Woodbridge 862
Chandler 851
Frankfurt am Main 617
Singapore 602
Dublin 593
Houston 576
Wilmington 548
Ashburn 503
Dearborn 351
Jacksonville 341
Seattle 340
New York 307
Cambridge 291
Hong Kong 261
Princeton 240
Milan 216
Santa Clara 195
Jakarta 145
Nanjing 143
Vienna 132
Shanghai 120
Altamura 113
Lawrence 105
Beijing 73
Guangzhou 59
San Diego 59
Lachine 56
Boardman 55
Dong Ket 52
Helsinki 49
Nanchang 48
Fremont 42
Toronto 36
Andover 33
Hebei 33
Brussels 32
Jinan 32
Shenyang 30
Lissone 26
Los Angeles 25
Jiaxing 24
Tianjin 24
Nuremberg 23
Brno 21
London 20
Norwalk 19
Falls Church 18
Hangzhou 18
Lappeenranta 18
Monza 18
Rome 18
Ottawa 17
Munich 16
Brescia 15
Mountain View 15
Ningbo 15
Changsha 14
Zhengzhou 13
Pune 12
Edmonton 11
Hefei 11
Florence 10
Beauharnois 9
Kiev 9
Kocaeli 9
Paris 9
Desio 8
Genoa 8
Kunming 8
Phoenix 8
Tappahannock 8
Turin 8
Auburn Hills 7
Chicago 7
Dallas 7
Leawood 7
Washington 7
Ansbach 6
Bari 6
Berlin 6
Groningen 6
Montréal 6
Naples 6
Orange 6
Redmond 6
Sacramento 6
Wuhan 6
Amsterdam 5
Carate Brianza 5
Changchun 5
Nürnberg 5
Padova 5
Sesto San Giovanni 5
Siena 5
São Paulo 5
Tokyo 5
Torre Annunziata 5
Upper Marlboro 5
Totale 13.241
Salva come PNG Salva come JPEG
Nome #
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 346
Noninvasive ventilation weaning in acute hypercapnic respiratory failure due to COPD exacerbation: A real-life observational study 307
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 294
Progressive fibrosing interstitial lung diseases: prevalence and characterization in two Italian referral centers 293
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights 289
Regional differences in bronchial reactivity assessed by respiratory impedance 237
Rehospitalization for pneumonia after first pneumonia admission: Incidence and predictors in a population-based cohort study 237
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 229
Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study" 227
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 219
Dyspnea in crackling lungs 218
Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia 209
Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis 209
Impact of traffic-related air pollution on pulmonary oxidative stress 204
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 200
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study 198
Characterization of bronchiectasis in the elderly 194
Renal involvement in Churg-Strauss syndrome 192
Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A single center experience and literature review 192
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential 192
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 190
162. Cluster analysis to explore clinical subclassification of eosinophilic granulomatosis with polyangiitis (churg–strauss) 190
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 189
HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome 186
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia 186
Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis 185
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 184
Clinical phenotypes in adult patients with bronchiectasis 182
Bronchoalveolar lavage in idiopathic pulmonary fibrosis: What does it tell us? 181
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 181
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 181
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 181
C-arm cone-beam CT-guided transthoracic lung core needle biopsy as a standard diagnostic tool 179
Management of acute respiratory failure in interstitial lung diseases: Overview and clinical insights 179
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study 179
Persistence with inhaled corticosteroids reduces the risk of exacerbation among adults with asthma: A real-world investigation 178
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 178
A 61-year-old female with chronic cough and purulent sputum 177
Il lavaggio broncoalveolare nelle pneumopatie infiltrative diffuse 174
An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything 174
Multidimensional severity assessment in bronchiectasis: An analysis of seven European cohorts 172
Alpha glucocorticoid receptor expression in different experimental rat models of acute lung injury 171
Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis 169
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 168
Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view? 165
Metallic elements in exhaled breath condensate of patients with interstitial lung diseases 164
Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity 163
Allergic bronchopulmonary aspergillosis screening in bronchiectasis: Is there always a precise answer to a clear question? 163
Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS? 160
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 160
Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy 159
Uterine carcinosarcoma metastatic to the lung as large-cell neuroendocrine carcinoma with synchronous sarcoid granulomatosis 155
Systemic sclerosis and outcome in intensive care unit: Do not close the door, open the right protocol 154
Can healthcare utilization data reliably capture cases of chronic respiratory diseases? A cross-sectional investigation in Italy 150
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 150
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 150
The management of community-acquired pneumonia in the elderly 147
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 147
COPD: maximization of bronchodilation 146
Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study 145
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study 143
A case of ARDS associated with influenza A - H1N1 infection treated with extracorporeal respiratory support 139
Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort study 137
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis 137
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 137
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study 135
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 134
Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis 130
Long-term macrolides in diffuse interstitial lung diseases 130
Interstitial lung diseases in a lung cancer screening trial 129
Geriatric multidimensional assessment for elderly patients with acute respiratory diseases 129
The bronchiectasis severity index. An international derivation and validation study 129
Optimization of ventilator setting by flow and pressure waveforms analysis during noninvasive ventilation for acute exacerbations of COPD: a multicentric randomized controlled trial 127
History of lung volume reduction procedures 127
Respiratory system involvement in systemic vasculitides 126
Non-tuberculous Mycobacterial Pulmonary Disease: an Italian National Survey 125
Macrolidi a lungo termine nella broncopneumopatia cronica ostruttiva 123
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial 121
Alveolar Diseases 119
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 118
Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia 118
Acute myocardial infarction versus other cardiovascular events in communityacquired pneumonia 117
Respiratory system involvement in ANCA-associated systemic vasculitides 114
Bronchoalveolar lavage in intensive care units 114
Right ventricular reverse remodelling in Idiopathic Pulmonary Arterial Hypertension diagnosed during pregnancy: Is it possible? 114
Molecular biomarkers in idiopathic pulmonary fibrosis: State of the art and future directions 111
The European IPF registry (eurIPFreg): Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis 111
Feasibility and clinical impact of a portable bi-level ventilation device in patients with severe chronic obstructive pulmonary disease and exertional dyspnea: preliminary results from a clinical series 109
Outcome and prognostic factors during the course of primary small-vessel vasculitides 107
Cryoglobulinemia 107
Reticular Diseases 106
EBUS-TBNA nella patologia mediastino-polmonare: analisi retrospettiva dei primi 3 anni di attività di un singolo centro 106
Cystic Diseases 105
Short-term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis 104
Interferon gamma e fibrosi polmonare idiopatica 103
Surgical and endoscopic treatment for COPD: Patients selection, techniques and results 102
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases 102
Respiratory System Involvement in Antineutrophil Cytoplasmic-associated Vasculitides: Clinical, pathological, radiological and therapeutic considerations 101
Nodular Diseases 97
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 97
Totale 16.218
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020890 0 0 0 0 0 0 0 220 254 185 152 79
2020/20213.017 112 111 256 348 281 265 291 346 281 312 169 245
2021/20221.968 194 206 232 210 109 161 65 95 75 140 156 325
2022/20233.101 347 865 350 289 186 471 36 179 215 22 82 59
2023/20241.995 52 61 107 97 247 551 367 90 122 33 32 236
2024/20252.224 282 524 250 205 411 247 258 47 0 0 0 0
Totale 18.516